MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on October 10, 2006; DOI: 10.1124/mol.106.030163


0026-895X/07/7101-92-100$20.00
Mol Pharmacol 71:92-100, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.030163v1
71/1/92    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Young, M. T.
Right arrow Articles by Surprenant, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Young, M. T.
Right arrow Articles by Surprenant, A.

Amino Acid Residues in the P2X7 Receptor that Mediate Differential Sensitivity to ATP and BzATP

Mark T. Young1, Pablo Pelegrin, and Annmarie Surprenant

Department of Biomedical Science, University of Sheffield, Sheffield, United Kingdom

Agonist properties of the P2X7 receptor (P2X7R) differ strikingly from other P2X receptors in two main ways: high concentrations of ATP (> 100 µM) are required to activate the receptor, and the ATP analog 2',3'-O-(4-benzoyl-benzoyl)ATP (BzATP) is both more potent than ATP and evokes a higher maximum current. However, there are striking species differences in these properties. We sought to exploit the large differences in ATP and BzATP responses between rat and mouse P2X7R to delineate regions or specific residues that may be responsible for the unique actions of these agonists at the P2X7R. We measured membrane currents in response to ATP and BzATP at wild-type rat and mouse P2X7R, at chimeric P2X7Rs, and at mouse P2X7Rs bearing point mutations. Wild-type rat P2X7R was 10 times more sensitive to ATP and 100 times more sensitive to BzATP than wild-type mouse P2X7R. We found that agonist EC50 values were determined solely by the ectodomain of the P2X7R. Two segments (residues 115-136 and 282-288), when transposed together, converted mouse sensitivities to those of rat. Point mutations through these regions revealed a single residue, asparagine284, in the rat P2X7R that fully accounted for the 10-fold difference in ATP sensitivity, whereas the 100-fold difference in BzATP sensitivity required the transfer of both Lys127 and Asn284 from rat to mouse. Thus, single amino acid differences between species can account for large changes in agonist effectiveness and differentiate between the two widely used agonists at P2X7 receptors.


Received August 26, 2006; accepted October 10, 2006

Address correspondence to: Dr. Annmarie Surprenant, Department of Biomedical Science, Addison Building Western Bank, University of Sheffield, Sheffield S10 2TN, UK. E-mail: a.surprenant{at}sheffield.ac.uk




This article has been cited by other articles:


Home page
J. Physiol.Home page
G. Casas-Pruneda, J. P. Reyes, G. Pérez-Flores, P. Pérez-Cornejo, and J. Arreola
Functional interactions between P2X4 and P2X7 receptors from mouse salivary epithelia
J. Physiol., June 15, 2009; 587(12): 2887 - 2901.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. Ma, H. Hui, P. Pelegrin, and A. Surprenant
Pharmacological Characterization of Pannexin-1 Currents Expressed in Mammalian Cells
J. Pharmacol. Exp. Ther., February 1, 2009; 328(2): 409 - 418.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. Adriouch, P. Bannas, N. Schwarz, R. Fliegert, A. H. Guse, M. Seman, F. Haag, and F. Koch-Nolte
ADP-ribosylation at R125 gates the P2X7 ion channel by presenting a covalent ligand to its nucleotide binding site
FASEB J, March 1, 2008; 22(3): 861 - 869.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. R. J. Taylor, M. Gonzalez-Begne, S. Dewhurst, G. Chimini, C. F. Higgins, J. E. Melvin, and J. I. Elliott
Sequential Shrinkage and Swelling Underlie P2X7-Stimulated Lymphocyte Phosphatidylserine Exposure and Death
J. Immunol., January 1, 2008; 180(1): 300 - 308.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
X. Liu, A. Surprenant, H.-J. Mao, S. Roger, R. Xia, H. Bradley, and L.-H. Jiang
Identification of Key Residues Coordinating Functional Inhibition of P2X7 Receptors by Zinc and Copper
Mol. Pharmacol., January 1, 2008; 73(1): 252 - 259.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics